Gefitinib (‘IRESSA’, ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation

Author: Bonaccorsi Lorella   Marchiani Sara   Muratori Monica   Forti Gianni   Baldi Elisabetta  

Publisher: Springer Publishing Company

ISSN: 0171-5216

Source: Journal of Cancer Research and Clinical Oncology, Vol.130, Iss.10, 2004-10, pp. : 604-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content